VITASPRING BIOMEDICAL CO., LTD. (VSBC) Return on equity 2017–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
57.7%FY2022 · since FY2017: -1.5% → 57.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 57.7% | -383.8 pp |
| FY2021 | 441.4% | — |
| FY2017 | -1.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice